SG11201607226UA - Codon-optimized nucleotide sequence encoding mg53, its recombinants and use thereof - Google Patents
Codon-optimized nucleotide sequence encoding mg53, its recombinants and use thereofInfo
- Publication number
- SG11201607226UA SG11201607226UA SG11201607226UA SG11201607226UA SG11201607226UA SG 11201607226U A SG11201607226U A SG 11201607226UA SG 11201607226U A SG11201607226U A SG 11201607226UA SG 11201607226U A SG11201607226U A SG 11201607226UA SG 11201607226U A SG11201607226U A SG 11201607226UA
- Authority
- SG
- Singapore
- Prior art keywords
- recombinants
- codon
- nucleotide sequence
- sequence encoding
- optimized nucleotide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410080068.5A CN103966227B (zh) | 2014-03-06 | 2014-03-06 | 密码子优化的mg53蛋白的编码核苷酸序列、其重组体及其应用 |
PCT/CN2015/071808 WO2015131728A1 (zh) | 2014-03-06 | 2015-01-29 | 密码子优化的mg53蛋白的编码核苷酸序列、其重组体及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201607226UA true SG11201607226UA (en) | 2016-10-28 |
Family
ID=51236233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201607226UA SG11201607226UA (en) | 2014-03-06 | 2015-01-29 | Codon-optimized nucleotide sequence encoding mg53, its recombinants and use thereof |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3118317A1 (de) |
JP (1) | JP2017508445A (de) |
CN (1) | CN103966227B (de) |
AU (1) | AU2015226729A1 (de) |
CA (1) | CA2938921A1 (de) |
HK (1) | HK1200867A1 (de) |
RU (1) | RU2016133188A (de) |
SG (1) | SG11201607226UA (de) |
WO (1) | WO2015131728A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103966227B (zh) * | 2014-03-06 | 2015-05-27 | 北京博雅和瑞科技有限公司 | 密码子优化的mg53蛋白的编码核苷酸序列、其重组体及其应用 |
CN104877971B (zh) * | 2015-06-02 | 2018-03-30 | 汉恒生物科技(上海)有限公司 | 一种可以缓解小鼠心衰症状的携带mg53基因的腺相关病毒载体 |
CA3031856A1 (en) | 2016-08-01 | 2018-02-08 | Peking University | Mg53 mutants, methods of making the same, and uses thereof |
CN106636175A (zh) * | 2016-09-30 | 2017-05-10 | 湖北科技学院 | 细胞损伤修复蛋白在毕氏酵母中的诱导表达、纯化方法及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9139630B2 (en) * | 2006-07-11 | 2015-09-22 | Rutgers, The State University Of New Jersey | Compositions and methods for preparing recombinant MG53 and methods for optimizing same |
CN101797375B (zh) * | 2009-12-02 | 2013-01-23 | 北京大学 | Mg53蛋白预防和/或治疗心脏缺血/再灌损伤的用途 |
CN103966227B (zh) * | 2014-03-06 | 2015-05-27 | 北京博雅和瑞科技有限公司 | 密码子优化的mg53蛋白的编码核苷酸序列、其重组体及其应用 |
-
2014
- 2014-03-06 CN CN201410080068.5A patent/CN103966227B/zh active Active
-
2015
- 2015-01-29 JP JP2016548052A patent/JP2017508445A/ja active Pending
- 2015-01-29 AU AU2015226729A patent/AU2015226729A1/en not_active Abandoned
- 2015-01-29 EP EP15759204.9A patent/EP3118317A1/de not_active Withdrawn
- 2015-01-29 SG SG11201607226UA patent/SG11201607226UA/en unknown
- 2015-01-29 CA CA2938921A patent/CA2938921A1/en not_active Abandoned
- 2015-01-29 WO PCT/CN2015/071808 patent/WO2015131728A1/zh active Application Filing
- 2015-01-29 RU RU2016133188A patent/RU2016133188A/ru not_active Application Discontinuation
- 2015-02-02 HK HK15101117.9A patent/HK1200867A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP2017508445A (ja) | 2017-03-30 |
EP3118317A1 (de) | 2017-01-18 |
RU2016133188A (ru) | 2018-02-14 |
CA2938921A1 (en) | 2015-09-11 |
WO2015131728A1 (zh) | 2015-09-11 |
HK1200867A1 (en) | 2015-08-14 |
CN103966227B (zh) | 2015-05-27 |
AU2015226729A1 (en) | 2016-08-25 |
CN103966227A (zh) | 2014-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL250498A0 (en) | modified nucleotide connectors | |
EP3218519A4 (de) | Multi-pass-sequenzierung | |
PL3102722T3 (pl) | Frakcjonowanie genomu | |
IL250836B (en) | Nucleotide analogs | |
GB201411344D0 (en) | Cloning | |
SG11201610182SA (en) | Molecular inks | |
HK1232169A1 (zh) | 取代的 -苯基哌啶,其製備和用途 | |
GB201415846D0 (en) | Catalyst | |
HUE056192T2 (hu) | Pullulanázvariánsok és azokat kódoló polinukleotidok | |
HUE052730T2 (hu) | Eljárás klór elõállításához használt katalizátor elõállítására, katalizátor és eljárás klór elõállítására | |
GB201402109D0 (en) | Catalyst | |
IL251255A0 (en) | Electric combustion reactor | |
IL253967B (en) | Resistant herbicide protein, gene encoded and compatible use | |
AP2016009428A0 (en) | Catalyst | |
ZA201705395B (en) | Herbicide-resistant protein, encoding gene and use thereof | |
SG11201607226UA (en) | Codon-optimized nucleotide sequence encoding mg53, its recombinants and use thereof | |
SG11201700099PA (en) | Oxidase, polynucleotide encoding same, and use thereof | |
IL249897A0 (en) | 2-oxo-4,3-dihydropyridine-5-carboxylates and their use | |
IL249073A0 (en) | Cytin-glucan complex, its preparation and uses | |
AU364261S (en) | Electrosurgical Pen | |
AU364259S (en) | Electrosurgical Pen | |
GB201515996D0 (en) | Synthetic nucleotide sequences | |
GB201501738D0 (en) | S.o.s.i.c.h. | |
GB201412854D0 (en) | Rhymeshow code | |
TWM490407U (en) | Key pen structure |